A carregar...
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine
Introduction: Proton Pump inhibitors (PPIs) are commonly used for a variety of acid related disorders. Despite the overall effectiveness and safety profile of PPIs, some patients do not respond adequately or develop treatment related adverse events. This variable response among patients is in part d...
Na minha lista:
| Publicado no: | Expert Opin Drug Metab Toxicol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942154/ https://ncbi.nlm.nih.gov/pubmed/29620484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17425255.2018.1461835 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|